Related Experiment Video
Updated: Jun 6, 2025

06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
Sleep Treatment Education Program for Cancer Survivors: Protocol for an Efficacy Trial
Briana L Bice1, Alexis L Michaud1,2, Katherine G McCormick1
1Perini Family Survivors' Center, Dana-Farber Cancer Institute, Boston, MA, United States.
JMIR Research Protocols
|November 28, 2024
Summary
Cancer survivors with insomnia can benefit from the Sleep Treatment Education Program (STEP-1), an online intervention improving sleep and mood. Further trials will explore its efficacy in diverse populations.
Area of Science:
- Oncology
- Sleep Medicine
- Psychology
Background:
- Cancer survivors experience chronic insomnia, increasing long-term health risks.
- Cognitive Behavioral Therapy for Insomnia (CBTI) is effective but inaccessible to many survivors due to barriers like distance and provider shortages.
- The Sleep Treatment Education Program (STEP-1) offers a low-intensity, online CBTI-based intervention to address these limitations.
Purpose of the Study:
- To evaluate the efficacy of STEP-1 in improving insomnia symptoms and mood in cancer survivors.
- To explore factors associated with treatment response, intervention acceptability, and feasibility of coaching.
- To assess participant satisfaction and gather suggestions for STEP-1 improvement.
Main Methods:
- A phase II pilot randomized controlled trial involving 70 off-treatment cancer survivors (aged 40-89) with insomnia.
- Participants were randomized to receive either the STEP-1 intervention or a relaxation education control condition via virtual sessions.
- Insomnia symptoms (Insomnia Severity Index) and mood (Profile of Mood States Short Form) were assessed at baseline and 4 and 8 weeks.
Main Results:
- Enrollment of 70 participants concluded in October 2024.
- Data analysis is scheduled for fall 2024, with results anticipated in winter 2025.
- The study is currently awaiting results to determine the efficacy of STEP-1.
Conclusions:
- Results will indicate if STEP-1 offers benefits beyond placebo effects.
- If effective, STEP-1 could be developed for larger trials in diverse cancer survivor populations.
- The study aims to establish STEP-1 as an accessible treatment for insomnia in cancer survivors.
Related Concept Videos
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480

